Breast cancer (BC) is the most common cancer in women in Europe and worldwide, with a high prevalence in middle-aged and older women. The last years, the evolution in the existing treatment approaches have contributed to improved clinical outcomes and survival rates. Nevertheless, BC therapy-related cardiotoxicity, poses a severe impact in the short- and long-term Quality of Life (QoL) and associated survival of the BC patients. This study demonstrates how the CARDIOCARE platform and the developed risk stratification models provides healthcare professionals with a valuable tool for effectively managing BC patients, preventing treatment induced cardiotoxicity and improving their QoL. This is accomplished through the integration of multi-source patient-specific data from patient-oriented mobile applications and wearable sensors, and by the employment of beyond the state-of-the-art data mining and machine learning approaches.